NewEdge Advisors LLC Buys 12,202 Shares of ARK Genomic Revolution ETF $ARKG

NewEdge Advisors LLC grew its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 102.6% in the first quarter, according to its most recent disclosure with the SEC. The fund owned 24,092 shares of the company’s stock after buying an additional 12,202 shares during the period. NewEdge Advisors LLC’s holdings in ARK Genomic Revolution ETF were worth $637,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the stock. PNC Financial Services Group Inc. grew its position in ARK Genomic Revolution ETF by 53.2% during the first quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock worth $29,000 after buying an additional 378 shares in the last quarter. Rockefeller Capital Management L.P. raised its holdings in ARK Genomic Revolution ETF by 1.9% in the 4th quarter. Rockefeller Capital Management L.P. now owns 24,243 shares of the company’s stock valued at $702,000 after acquiring an additional 461 shares in the last quarter. FWL Investment Management LLC lifted its position in shares of ARK Genomic Revolution ETF by 17.1% in the 3rd quarter. FWL Investment Management LLC now owns 3,239 shares of the company’s stock worth $90,000 after acquiring an additional 474 shares during the period. Summit Investment Advisory Services LLC lifted its position in shares of ARK Genomic Revolution ETF by 5.6% in the 1st quarter. Summit Investment Advisory Services LLC now owns 9,270 shares of the company’s stock worth $245,000 after acquiring an additional 495 shares during the period. Finally, StoneX Group Inc. grew its holdings in shares of ARK Genomic Revolution ETF by 6.5% during the 4th quarter. StoneX Group Inc. now owns 8,746 shares of the company’s stock worth $253,000 after purchasing an additional 530 shares in the last quarter.

ARK Genomic Revolution ETF Stock Performance

ARKG opened at $47.64 on Friday. ARK Genomic Revolution ETF has a 1 year low of $23.75 and a 1 year high of $48.88. The stock’s 50 day simple moving average is $40.52 and its 200-day simple moving average is $33.29.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.